Memorial Sloan Kettering Cancer Center - Bergen — New York, New York

Public research footprint of Memorial Sloan Kettering Cancer Center - Bergen, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

Non-Hodgkin Lymphoma Refractory/ Relapsed · Early Stage Lung Cancer · Metastatic Breast Cancer · Uncommon EGFR Mutations

Recently updated registry entries

NCT07121946 — This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin… (Recruiting)
NCT06827236 — A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323… (Recruiting)
NCT07128199 — A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Memorial Sloan Kettering Cancer Center - Bergen?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.